Inventor · disambiguated record
Xiaoling Song
Also filed as: SONG XIAOLING
11 granted patents·10 pending applications·50 citations·filing 2001–2024
87Inventor score
Files withEPIGENOMICS AG9UNIV SHANGHAI TECHNOLOGY4DEFINED DIAGNOSTICS LLC1DISTLER JUERGEN1LOFTON-DAY CATHERINE E1
Top patents by PatentIndex Score
21 records- 0195US7749702B2Methods and nucleic acids for the analyses of cellular proliferative disordersEPIGENOMICS AG·Filed 2006·Granted Jul 6, 2010·32 cites·22 claims
- 0289US8900829B2Methods and nucleic acids for analyses of cellular proliferative disordersDISTLER JUERGEN·Filed 2011·Granted Dec 2, 2014·9 cites·8 claims
- 0388US11771709B2ALK protein degradation agent and anti-tumor application thereofUNIV SHANGHAI TECHNOLOGY·Filed 2020·Granted Oct 3, 2023·3 cites·44 claims
- 0486US11186879B2Methods and nucleic acids for analyses of cellular proliferative disordersEPIGENOMICS AG·Filed 2019·Granted Nov 30, 2021·1 cites·15 claims
- 0580US10385402B2Methods and nucleic acids for analyses of cellular proliferative disordersEPIGENOMICS AG·Filed 2016·Granted Aug 20, 2019·1 cites·16 claims
- 0679US2022154287A1Methods and nucleic acids for analyses of cellular proliferative disordersEPIGENOMICS AG·Filed 2021·Application pending·0 cites
- 0777US12226424B2Target protein degradation compounds, their anti-tumor use, their intermediates and use of intermediatesUNIV SHANGHAI TECHNOLOGY·Filed 2019·Granted Feb 18, 2025·2 cites·17 claims
- 0870US9695478B2Methods and nucleic acids for the analyses of cellular proliferative disordersLOFTON-DAY CATHERINE E·Filed 2010·Granted Jul 4, 2017·1 cites·5 claims
- 0970US2025064837A1Target protein degradation compounds, their anti-tumor use, their intermediates and use of intermediatesUNIV SHANGHAI TECHNOLOGY·Filed 2024·Application pending·0 cites
- 1069US7951563B2Methods and nucleic acids for analysis of cellular proliferative disordersEPIGENOMICS AG·Filed 2006·Granted May 31, 2011·1 cites·8 claims
- 1165US2015086989A1Methods and nucleic acids for analyses of cellular proliferative disordersEPIGENOMICS AG·Filed 2014·Application pending·0 cites
- 1260US2009144857A1Receptors for hypersensitive response elicitors and uses thereofPLANT HEALTH CARE INC·Filed 2008·Application pending·0 cites
- 1359US2005246799A1Receptors for hypersensitive response elicitors and uses thereofSONG XIAOLING·Filed 2004·Application pending·0 cites
- 1454US2010184027A1Methods and nucleic acids for analyses of cellular proliferative disordersEPIGENOMICS AG·Filed 2007·Application pending·0 cites
- 1552US9926573B2Glyphosate-tolerant gene and use thereofUNIV NANJING AGRICULTURAL·Filed 2013·Granted Mar 27, 2018·0 cites·5 claims
- 1651US2003177526A1Receptors for hypersensitive response elicitors and uses thereofFiled 2002·Application pending·0 cites
- 1749US2016312287A1Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disordersEPIGENOMICS AG·Filed 2015·Application pending·0 cites
- 1846US2009197250A1Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disordersEPIGENOMICS AG·Filed 2005·Application pending·0 cites
- 1944US12390532B2ALK protein regulator and anti-tumor application thereofUNIV SHANGHAI TECHNOLOGY·Filed 2020·Granted Aug 19, 2025·0 cites·9 claims
- 2035US2002007501A1Receptors for hypersensitive response elicitors and uses thereofFiled 2001·Application pending·0 cites
- 2123US11061028B2Compositions and methods for the diagnosis of lyme diseaseDEFINED DIAGNOSTICS LLC·Filed 2015·Granted Jul 13, 2021·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Xiaoling Song files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →